13 January 2026
Antibodies | Most Viewed Papers in 2025
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
1. “Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer Treatment”
by Hyukmin In, Minkyoung Park, Hyeonsik Lee and Kyung Ho Han
Antibodies 2025, 14(1), 16; https://doi.org/10.3390/antib14010016
Available online: https://www.mdpi.com/2073-4468/14/1/16
2. “Fragment-Based Immune Cell Engager Antibodies in Treatment of Cancer, Infectious and Autoimmune Diseases: Lessons and Insights from Clinical and Translational Studies”
by Ge Yang and Mohammad Massumi
Antibodies 2025, 14(3), 52; https://doi.org/10.3390/antib14030052
Available online: https://www.mdpi.com/2073-4468/14/3/52
3. “Challenges and Insights in Absolute Quantification of Recombinant Therapeutic Antibodies by Mass Spectrometry: An Introductory Review”
by Sarah Döring, Michael G. Weller, Yvonne Reinders, Zoltán Konthur and Carsten Jaeger
Antibodies 2025, 14(1), 3; https://doi.org/10.3390/antib14010003
Available online: https://www.mdpi.com/2073-4468/14/1/3
4. “FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia”
by Michael Sandhu and Irina Murakhovskaya
Antibodies 2025, 14(3), 65; https://doi.org/10.3390/antib14030065
Available online: https://www.mdpi.com/2073-4468/14/3/65
5. “How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza”
by Rebecca Steventon, Lucas Stolle and Craig Peter Thompson
Antibodies 2025, 14(1), 4; https://doi.org/10.3390/antib14010004
Available online: https://www.mdpi.com/2073-4468/14/1/4
6. “Future Landscape of Anti-Claudin 18.2 Antibodies in Gastric Adenocarcinoma”
by Wendy M. Covert and Jane E. Rogers
Antibodies 2025, 14(1), 26; https://doi.org/10.3390/antib14010026
Available online: https://www.mdpi.com/2073-4468/14/1/26
7. “Anti-ADAMTS13 Autoantibodies in Immune-Mediated Thrombotic Thrombocytopenic Purpura”
by Michael R. Snyder and Robert W. Maitta
Antibodies 2025, 14(1), 24; https://doi.org/10.3390/antib14010024
Available online: https://www.mdpi.com/2073-4468/14/1/24
8. “Avian Antibodies as Potential Therapeutic Tools”
by Mats Eriksson and Anders Larsson
Antibodies 2025, 14(1), 18; https://doi.org/10.3390/antib14010018
Available online: https://www.mdpi.com/2073-4468/14/1/18
9. “Infertility and Auto-Antibodies: A Review”
by Brigita Šemeklienė and Brigita Gradauskienė
Antibodies 2025, 14(3), 76; https://doi.org/10.3390/antib14030076
Available online: https://www.mdpi.com/2073-4468/14/3/76
10. “A Targeted Integration-Based CHO Cell Platform for Simultaneous Antibody Display and Secretion”
by Jessica P. Z. Ng, Mariati Mariati, Jiawu Bi, Matthew Wook Chang and Yuansheng Yang
Antibodies 2025, 14(2), 38; https://doi.org/10.3390/antib14020038
Available online: https://www.mdpi.com/2073-4468/14/2/38